Rheumatoid Arthritis Clinical Trials in Aurora, Colorado

4 studies are recruiting for rheumatoid arthritis in Aurora, Colorado right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis

    This study will test the safety and effects of SBT777101 when given as a single dose to subjects with rheumatoid arthritis. It is the first study of this treatment being done in humans. Increasing dose levels will be given after the safety at lower dose levels is shown. Following completion of the …

    Stage
    Phase 1
    Ages
    18 to 70
    Site
    University of Colorado, Aurora, Colorado
    Locations
    9 in total
    Run by
    Sonoma Biotherapeutics, Inc.

    See if you can join NCT06201416 on ClinicalTrials.gov

  2. A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

    Phase II study in participants with moderately-to-severely active rheumatoid Arthritis (RA) to evaluate efficacy and safety of AZD1163.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Research Site, Aurora, Colorado
    Locations
    144 in total
    Run by
    AstraZeneca

    See if you can join NCT07276581 on ClinicalTrials.gov

  3. Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease

    The overall goal of this study is to define the phenotype of Interstitial Lung Disease (ILD), and identify factors that predict radiologic progression in those with subclinical RA-ILD, in patients with rheumatoid arthritis (RA). The investigators hypothesize that there are common core elements (e.g…

    Stage
    Not phased
    Ages
    45 to 90
    Site
    University of Colorado - Anschutz Medical Campus, Aurora, Colorado
    Run by
    University of Colorado, Denver

    See if you can join NCT03297775 on ClinicalTrials.gov

  4. Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

    A study to identify patients with Rheumatoid Arthritis - Associated Interstitial Lung Disease (RA-ILD) that are at the highest risk for progression. The goal of the investigators is to recruit a group of patients with RA-ILD and collect information to help us understand more about disease progressi…

    Stage
    Not phased
    Ages
    18 to 90
    Site
    University of Colorado Denver, Aurora, Colorado
    Locations
    4 in total
    Run by
    University of Colorado, Denver

    See if you can join NCT06397677 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.